Encellin

About:

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

Top Investors: Khosla Ventures, Y Combinator, Sand Hill Angels, Formic Ventures, Endurance28

Description:

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.

Total Funding Amount:

$15.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)encellin.com

Founders:

Crystal Nyitray, Grace Wei, Ronald Martell

Number of Employees:

1-10

Last Funding Date:

2023-12-13

IPO Status:

Private

Industries: